Lucid Capital Markets, LLC (“Lucid”), a full-service investment bank, is pleased to announce two key additions to its healthcare equity research team with the hiring of Christopher Liu, PharmD, as Managing Director and Dev Prasad, Ph.D., MBA, as Senior Vice President. Both Christopher and Dev will be responsible for covering various therapeutic areas across the healthcare sector.
Christopher joins Lucid with over seven years of equity research experience with a specialization in oncology. Most recently, Christopher was a Director at Leerink Partners covering the oncology space. Prior to Leerink, Christopher was part of the biotechnology equity research teams at Canaccord Genuity and Oppenheimer. Christopher received his Doctor of Pharmacy from Rutgers University's Ernest Mario School of Pharmacy.
Dev brings ~four years of experience in equity research to Lucid specializing in inflammation and immunology. Prior to joining Lucid, Dev was a member of the equity research teams at Jefferies and JMP Securities. Before his transition into equity research, Dev worked on the product development teams at Fresenius, Sagent Pharmaceuticals and Cubist Pharma. He holds a Ph.D. and a Master of Science in Pharmaceutics and Drug Delivery from the Massachusetts College of Pharmacy and Health Sciences, along with an MBA from Northwestern University's Kellogg School of Management.
“We are excited to welcome Chris and Dev to Lucid’s equity research team. Chris and Dev bring extensive industry and research experience to the Lucid Healthcare Group, showcasing Lucid’s dedication to providing top-tier expertise. Lucid is thrilled to further strengthen its equity research team following the recent additions of Eric Zwick, covering specialty finance, and Craig Kucera, specializing in REITs,” said David Rosenberg, CEO Lucid Capital Markets - IB.
ABOUT LUCID CAPITAL MARKETS
Lucid is a full-service middle-market investment bank specializing in a broad range of financial services across various growth sectors of the economy. With decades of experience, our senior leadership has developed a client-focused and relationship-driven approach to our business, prioritizing success by tailoring solutions to each client's needs.
At its core, Lucid's main priority is building and maintaining relationships, ensuring every client receives the highest level of personal attention from senior professionals who strive to exceed expectations. Our team's professional experience across M&A advisory, capital markets, equity research, floor brokerage and institutional sales & trading enables Lucid to provide unmatched expertise.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240821047926/en/
